Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers

Journal of Pharmaceutical Sciences

Volumn 89, Issue 2, 2000, Pages 250-259

  Kachrimanis, Kyriakos ^a   Nikolakakis, Ioannis ^a   Malamataris, Stavros ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EUDRAGIT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER;

ARTICLE; CRYSTALLIZATION; DRUG FORMULATION; DRUG SOLUBILITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION;

EID: 0033998382     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6017(200002)89:2<250::AID-JPS12>3.0.CO;2-W     Document Type: Article

References (20)

1. Insel PA. 1990. Analgesic-antipyretics and antiinflammatory agents. In: Gilman AG, Rail TW, Nies AS, Taylor P, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon. p 665-666.
2. Benita S, Hoffman A, Donbrow M. 1985. Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model. J Pharm Pharmacol 37:391-395.
3. Cammeron CG, McGinity JW. 1987. Controlled release theophylline tablet formulations containing acrylic resins: II. Combination resin formulations. Drug Dev Ind Pharm 13:1409-1427.
4. Lehmann K. 1989. Chemistry and application properties of polymethacrylate coating systems. In: McGinity JW, editor. Aqueous polymeric coatings for pharmaceutical applications. New York: Dekker. p 153-245.
5. Huang HP, Mehta SC, Radebaugh GW, Fawzi MB. 1993. Mechanism of drug release from an acrylic polymer-wax matrix tablet. J Pharm Sci 83: 795-797.
6. Ardizzone S, Petrillo M, Molteni P, Desideri S, Bianchi Porro G. 1995. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study. J Clin Gastroenterol 21: 287-289.
7. Jenquin MR, Liebowitz SM, Sarabia RE, McGinity JW. 1990. Physical and chemical factors influencing the release of drugs from acrylic resin films. J Pharm Sci 79:811-816.
8. Kislalioglou MS, Khan MA, Blount C, Goettsch RW, Bolton S. 1991. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J Pharm Sci 80:799-804.
9. Khan KA, Bolton S, Kislalioglou MS. 1994. Optimization of process variables for the preparation of ibuprofen coprecipitates with Eudragit S100. Int J Pharm 102:185-192.
10. Kachrimanis K, Ktistis G, Malamataris S. 1998. Crystallisation conditions and physicomechanical properties of ibuprofen-Eudragit S100 spherical crystal agglomerates prepared by the solvent change technique. Int J Pharm 173:61-74.
11. Kawashima Y, Okumura M, Takenaka H. 1982. Spherical crystallization: direct spherical agglomeration of salicylic acid crystals during crystallization. Science 216:1127-1128.
12. Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. 1989. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J Pharm Sci 78:68-72.
13. Ribardiere A, Tchoreloff P, Couarraze G, Puisieux F. 1996. Modification of ketoprofen bead structure by the spherical crystallization technique with a two-solvent system. Int J Pharm 144:195-207.
14. Flook AG. 1978. The use of dilation logic on the Quantimet to achieve fractal dimension characterization of textured and structured profiles. Powder Technol 21:295-298.
15. Strickland WA Jr, Busse LW, Higuchi T. 1956. The physics of tablet compression XI. Determination of porosity of tablet granulations. J Am Pharm Assoc 45:482-486.
16. Jenquin M, McGinity J. 1994. Characterization of acrylic resin matrix films and mechanisms of drug-polymer interactions. Int J Pharm 101:23-34.
17. Mullin JW. 1993. Crystallization, 3rd ed. Oxford: Butterworth-Heinemann. p 189-193.
18. Heckel RW. 1961. An analysis of powder compaction phenomena. Trans Met Soc AIME, 221: 671-675.
19. Schulze MD, McGinity JW. 1993. Indices of tableting performance for acrylic resin polymers with plastic and brittle drugs. Drug Dev Ind Pharm 19: 1393-1411.
20. Hiestand NE. 1996. Rationale for and the measurement of tableting indices. In: Alderborn G, Nystrom C, editors. Pharmaceutical powder compaction technology. New York: Dekker. p 243.